These therapeutics also drive cancer cell heterogeneity and the emergence of chemorefractory clones with metastatic properties acquired e.g. via EMT by upregulation of transcription factors like HIF1α, Snail, Slug or Twist 270,71. This evidence concerns the gene SNAI2 and cancer.